Breaking News Instant updates and real-time market news.

ELGX

Endologix

$4.74

0.04 (0.85%)

16:04
08/09/18
08/09
16:04
08/09/18
16:04

Endologix cuts FY18 GAAP EPS view to ($1.12)-($1.04) from (95c)-(89c)

Consensus (58c). Cuts FY18 revenue view to $145M-$155M from $170M-$180M, consensus $175.6M.

  • 09

    Aug

  • 06

    Nov

ELGX Endologix
$4.74

0.04 (0.85%)

10/09/17
ADAM
10/09/17
NO CHANGE
Target $5
ADAM
Hold
Endologix investors should take profits, says Canaccord
Canaccord analyst Jason Mills believes the run in Endologix shares following the FDA approval of the NELLIX confirmatory study is "egregiously overdone" and as a result investors should take profits. Mills, who remains cautious about the company's ability to gain market share in a highly competitive and mature market, maintained his Hold rating and $5.00 price target on Endologix shares.
12/12/17
PIPR
12/12/17
INITIATION
Target $7
PIPR
Overweight
Endologix assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brian assumed coverage of Endologix with an Overweight rating and $7 price target. The analyst views the company as a "solid player" in the abdominal aortic aneurysms space despite some setbacks.
01/02/18
JPMS
01/02/18
DOWNGRADE
Target $5
JPMS
Underweight
Endologix downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Weinstein downgraded Endologix to Underweight and cut his price target for the shares to $5 from $6. The outlook for the company continued to "deteriorate" over the course of 2017 as pipeline and regulatory challenges mounted, Weinstein tells investors in a research note. He sees an "uncertain path to profitability" and a "very long" road to recovery for Endologix.
03/20/18
PIPR
03/20/18
NO CHANGE
PIPR
Endologix ENCORE study a positive sign, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien was positive on Endologix's ENCORE study results for its Ovation product, and continues to believe "additional data reads and imminent approvals in the coming years should lift shares higher." O'Brien maintained an Overweight rating on shares, recommending investors with more risk tolerance or a longer time horizon accumulate shares at this point.

TODAY'S FREE FLY STORIES

HOG

Harley-Davidson

$39.54

-0.17 (-0.43%)

14:12
04/23/19
04/23
14:12
04/23/19
14:12
On The Fly
Trump Effect: Harley points to tariff impact as Trump vows to 'reciprocate' »

Shares of Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 09

    May

AG

First Majestic

$5.99

0.105 (1.78%)

14:05
04/23/19
04/23
14:05
04/23/19
14:05
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 10

    May

F

Ford

$9.45

0.105 (1.12%)

, AMZN

Amazon.com

$1,926.80

38.7 (2.05%)

14:02
04/23/19
04/23
14:02
04/23/19
14:02
Hot Stocks
Ford, Autonomic announce multi-year, global agreement with Amazon Web Services »

Ford Motor (F) and…

F

Ford

$9.45

0.105 (1.12%)

AMZN

Amazon.com

$1,926.80

38.7 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 10

    May

  • 22

    May

  • 03

    Jun

  • 24

    Jul

  • 23

    Oct

F

Ford

$9.46

0.115 (1.23%)

, AMZN

Amazon.com

$1,926.53

38.43 (2.04%)

14:01
04/23/19
04/23
14:01
04/23/19
14:01
Hot Stocks
Breaking Hot Stocks news story on Ford, Amazon.com »

Ford, Autonomic announce…

F

Ford

$9.46

0.115 (1.23%)

AMZN

Amazon.com

$1,926.53

38.43 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 10

    May

  • 22

    May

  • 03

    Jun

  • 24

    Jul

  • 23

    Oct

TWTR

Twitter

$39.82

5.43 (15.79%)

13:59
04/23/19
04/23
13:59
04/23/19
13:59
Recommendations
Twitter analyst commentary at Baird »

Twitter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

ADNT

Adient

$25.11

-0.43 (-1.68%)

13:55
04/23/19
04/23
13:55
04/23/19
13:55
Options
Adient put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

TNXP

Tonix Pharmaceuticals

$2.29

-0.035 (-1.51%)

13:54
04/23/19
04/23
13:54
04/23/19
13:54
Hot Stocks
Tonix Pharmaceuticals says USAMMDA exercising right to terminate CRADA »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

TNXP

Tonix Pharmaceuticals

$2.29

-0.035 (-1.51%)

13:52
04/23/19
04/23
13:52
04/23/19
13:52
Hot Stocks
Breaking Hot Stocks news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

AGN

Allergan

$142.87

2.6 (1.85%)

, TEVA

Teva

$15.14

0.435 (2.96%)

13:50
04/23/19
04/23
13:50
04/23/19
13:50
Conference/Events
Piper Jaffray specialty pharma analysts to hold analyst/industry conference call »

Specialty Pharmaceuticals…

AGN

Allergan

$142.87

2.6 (1.85%)

TEVA

Teva

$15.14

0.435 (2.96%)

ALDR

Alder Biopharmaceuticals

$13.55

0.78 (6.11%)

AMGN

Amgen

$180.01

3.81 (2.16%)

BHVN

Biohaven Pharmaceutical

$63.34

2.39 (3.92%)

LLY

Eli Lilly

$117.60

2.16 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

TWTR

Twitter

$39.95

5.56 (16.17%)

13:44
04/23/19
04/23
13:44
04/23/19
13:44
Recommendations
RBC 'more constructive' on Twitter post results, boosts price target to $38 »

In a post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

BRFS

BRF S.A.

$7.54

0.44 (6.20%)

13:40
04/23/19
04/23
13:40
04/23/19
13:40
Options
Renewed call buying in BRF SA as shares rally 6.5% »

Renewed call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PW

Power REIT

$5.74

-0.075 (-1.29%)

13:39
04/23/19
04/23
13:39
04/23/19
13:39
Hot Stocks
Cascadilla Capital Partners urges sale or liquidation of Power REIT »

Todd Merkle, Managing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$31.44

1.21 (4.00%)

13:36
04/23/19
04/23
13:36
04/23/19
13:36
Recommendations
PulteGroup analyst commentary  »

PulteGroup price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 08

    May

MBRX

Moleculin Biotech

$1.60

-1.37 (-46.13%)

13:35
04/23/19
04/23
13:35
04/23/19
13:35
Hot Stocks
Sabby Management reports 7.14% passive stake in Moleculin Biotech »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

LMT

Lockheed Martin

$336.62

21.38 (6.78%)

13:31
04/23/19
04/23
13:31
04/23/19
13:31
Hot Stocks
Lockheed Martin receives $362M contract for MLRS launchers »

The U.S. Army awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 29

    May

  • 05

    Jun

13:30
04/23/19
04/23
13:30
04/23/19
13:30
General news
Treasury Action: yields remain lower after a well received 2-year auction »

Treasury Action: yields…

TCEHY

Tencent

$0.00

(0.00%)

, KKR

KKR

$23.76

0.33 (1.41%)

13:28
04/23/19
04/23
13:28
04/23/19
13:28
Periodicals
Epic workers describe 'Fortnite' working environment as toxic, Polygon says »

Current and former…

TCEHY

Tencent

$0.00

(0.00%)

KKR

KKR

$23.76

0.33 (1.41%)

DIS

Disney

$133.00

1.3 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 08

    May

  • 15

    May

  • 11

    Jun

TSLA

Tesla

$264.55

1.65 (0.63%)

13:26
04/23/19
04/23
13:26
04/23/19
13:26
Hot Stocks
Tesla electric vehicle challenger Lucid Motors appoints Peter Rawlinson as CEO »

Electric car start-up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

PAGS

PagSeguro Digital

$26.03

0.375 (1.46%)

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Options
PagSeguro Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$276.37

4.14 (1.52%)

, CRM

Salesforce

$160.44

1.69 (1.06%)

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Conference/Events
Stephens eCommerce analysts to hold an analyst/industry conference call »

Analysts provide an…

ADBE

Adobe

$276.37

4.14 (1.52%)

CRM

Salesforce

$160.44

1.69 (1.06%)

SHOP

Shopify

$223.04

-1.28 (-0.57%)

SAP

SAP

$114.13

0.36 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 08

    May

  • 03

    Jun

  • 23

    Jun

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

DNLI

Denali Therapeutics

$24.10

-0.74 (-2.98%)

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Conference/Events
Denali Therapeutics participates in a conference call with JPMorgan »

SMid Biotech Analyst Fye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
04/23/19
04/23
13:17
04/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
04/23/19
04/23
13:16
04/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
04/23/19
04/23
13:15
04/23/19
13:15
General news
Treasury's $40 B 2-year auction was well received »

Treasury's $40 B…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.